Recombinant CD37 (Naratuximab Biosimilar) 抗体
This anti-CD37 (Naratuximab Biosimilar) antibody is a Humanized Chimeric antibody detecting CD37 (Naratuximab Biosimilar) in ELISA 和 WB. Suitable for 人.
Quick Overview for Recombinant CD37 (Naratuximab Biosimilar) 抗体 (ABIN7538072)
抗原
CD37 (Naratuximab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Humanized
克隆类型
Chimeric
标记
This CD37 (Naratuximab Biosimilar) antibody is un-conjugated
应用范围
ELISA, Western Blotting (WB)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Naratuximab Biosimilar – Anti-CD37 mAb - Research Grade
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
纯度
- > 85%
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS buffer PH7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- CD37 (Naratuximab Biosimilar)
-
背景
- Naratuximab is a humanized monoclonal antibody that binds CD37. Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine.
-
CAS-编号
- 1622327-39-2
抗原
-
You are here:
